Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions
Completed
Ranbaxy Laboratories Limited
N/A
2005-05-01
The objective of this study is to assess the single - dose relative bioavailability of
Ranbaxy and Bristol-Myers Squibb Company (CEFZIL ®) 500 mg cefprozil tablets, under fed
conditions.
Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions
Completed
Ranbaxy Laboratories Limited
N/A
2005-06-01
The study was conducted as a blinded, randomized, 3-way crossover study to compare the
single-dose relative bioavailability of Cefprozil 250 mg/5 mL Oral suspension versus Cefzil
TM Powder for Oral Suspension (250 mg/5 mL) following one 5 mL dose under fasting conditions
Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fed Conditions
Completed
Ranbaxy Laboratories Limited
N/A
2005-06-01
The study was conducted as an open-label, randomized, 2-way crossover study to compare the
single-dose relative bioavailability of Cefprozil 250 mg/5 mL Oral suspension versus Cefzil
TM Powder for Oral Suspension (250 mg/5 mL) following one 5 mL dose under fed conditions
Bioequivalence Study of Cefprozil Tablets, USP 500 mg Under Fasting Conditions
Completed
Ranbaxy Laboratories Limited
N/A
2005-05-01
The objective of this study was to assess the single-dose relative bioavailability of Ranbaxy
and Bristol-Myers Squibb Company (CEFZIL ®) 500 mg cefprozil tablets, under fasting
conditions.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
